Landipirdine (INN, USAN; developmental code names RO-5025181 and SYN-120) is a serotonin 5-HT2A and 5-HT6 receptor antagonist which was under development for the treatment of dementia and cognition disorders but was never marketed.
The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.